Avalon Pharma renews SAR 50M credit agreement with Alinma Bank

18/05/2025 Argaam
Logo ofMiddle East Pharmaceutical Industries Co. (Avalon Pharma)

Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma) 

Middle East Pharmaceutical Industries Co. (Avalon Pharma) renewed its SAR 50 million credit facility agreement with Alinma Bank to support its working capital and capital expenditure.

 

For more news on listed companies

 

In a statement to Tadawul, the company said the one-year facility was obtained on May 15, 2025.

 

The collateral provided includes a promissory note valued at SAR 55 million.

 

There are no related parties to the deal, the statement added.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.